Corona Crisis: Trial of 3rd dose of Covaxin begins in AIIMS

The clinical trial of third dose of Bharat Biotech's Covaxin has begun today in Delhi's AIIMS. ABP News spoke to Dr. Sanjay Rai, Principal Investigator of clinical trial of this vaccine in AIIMS. He informed that Bharat Biotech has received approval from the Subject Expert Committee of the Central Drug Standard Controller Organization. Watch this News report to know more.